[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 66, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Mr. Jerome Benedict Durso", "age": 57, "title": "Chairman, CEO & President", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 69, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 37, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin E. Abrams J.D.", "age": 61, "title": "General Counsel & Chief Legal Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 52, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda M. Richardson", "age": 61, "title": "Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christophe  Arbet-Engels M.B.A., M.D., Ph.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.49, "open": 4.49, "dayLow": 4.36, "dayHigh": 4.51, "regularMarketPreviousClose": 4.49, "regularMarketOpen": 4.49, "regularMarketDayLow": 4.36, "regularMarketDayHigh": 4.51, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": 0.076, "forwardPE": -3.5160673, "volume": 4121527, "regularMarketVolume": 4121527, "averageVolume": 4987915, "averageVolume10days": 3497240, "averageDailyVolume10Day": 3497240, "bid": 3.2, "ask": 5.6, "bidSize": 2, "askSize": 2, "marketCap": 548514048, "fiftyTwoWeekLow": 2.9, "fiftyTwoWeekHigh": 7.73, "allTimeHigh": 137.7, "allTimeLow": 1.51, "priceToSalesTrailing12Months": 27425.703, "fiftyDayAverage": 4.7006, "twoHundredDayAverage": 4.55405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 261762272, "profitMargins": 0.0, "floatShares": 103532734, "sharesOutstanding": 125231517, "sharesShort": 24163422, "sharesShortPriorMonth": 25810012, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.19299999, "heldPercentInsiders": 0.00713, "heldPercentInstitutions": 0.48905, "shortRatio": 3.78, "shortPercentOfFloat": 0.19389999, "impliedSharesOutstanding": 125231518, "bookValue": 1.941, "priceToBook": 2.256569, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -83915000, "trailingEps": -1.07, "forwardEps": -1.24571, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 13088.114, "enterpriseToEbitda": -2.897, "52WeekChange": -0.3009259, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 4.38, "targetHighPrice": 28.0, "targetLowPrice": 1.0, "targetMeanPrice": 17.66667, "targetMedianPrice": 20.0, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 210776000, "totalCashPerShare": 2.022, "ebitda": -90343000, "totalDebt": 15905000, "quickRatio": 16.831, "currentRatio": 17.183, "totalRevenue": 20000, "debtToEquity": 8.569, "revenuePerShare": 0.0, "returnOnAssets": -0.30868998, "returnOnEquity": -0.52615, "grossProfits": -67784000, "freeCashflow": -37671376, "operatingCashflow": -66352000, "revenueGrowth": 0.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4171.8, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1771635512, "regularMarketTime": 1771621202, "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.44988, "regularMarketPrice": 4.38, "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "dividendDate": 1536883200, "earningsTimestampStart": 1772112600, "earningsTimestampEnd": 1772112600, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.07, "epsForward": -1.24571, "epsCurrentYear": -0.97714, "priceEpsCurrentYear": -4.4824696, "fiftyDayAverageChange": -0.32060003, "fiftyDayAverageChangePercent": -0.06820406, "twoHundredDayAverageChange": -0.17404985, "twoHundredDayAverageChangePercent": -0.038218696, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "postMarketChangePercent": 0.018256985, "postMarketPrice": 4.3808, "postMarketChange": 0.0007996559, "regularMarketChange": -0.11, "regularMarketDayRange": "4.36 - 4.51", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4987915, "fiftyTwoWeekLowChange": 1.48, "fiftyTwoWeekLowChangePercent": 0.5103448, "fiftyTwoWeekRange": "2.9 - 7.73", "fiftyTwoWeekHighChange": -3.35, "fiftyTwoWeekHighChangePercent": -0.43337643, "fiftyTwoWeekChangePercent": -30.09259, "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]